or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
lung cancer PhD Projects, Programmes & Scholarships
We have 32 lung cancer PhD Projects, Programmes & Scholarships
Validation of novel combination treatments in lung cancer
Lung cancer is the leading cause of cancer-related deaths and the most common cancer in men and the 2nd most common cancer in women worldwide. Read more
(MCRC Clinical) Microenvironment sensing and mechano-regulation of gene expression in non-small cell lung cancer
Increasing early diagnosis is one of the biggest steps towards improving health outcomes and reducing both the economic and patient impacts of cancer. Read more
Cancer biology: identification of new treatment options for EML4-ALK driven lung cancer through understanding mechanisms of cell division and migration.
Lung cancer is the largest cause of cancer-related deaths in the UK and worldwide. While little progress has been made in long-term survival rates, we now have a good understanding of the genetic drivers raising the prospect of earlier diagnosis and more effective treatments. Read more
PhD Opportunity - Investigating the prognostic value of spatial immunophenotypes in lung cancer
'TO APPLY, PLEASE CLICK INSTITUTION WEBSITE'. Project description. Tumour microenvironments (TMEs) profoundly influence cancer progression and shape the response to anti-cancer therapy. Read more
(MCRC Clinical) The VIGILANCE study: developing imaging and circulating biomarkers towards personalised radiotherapy in locally advanced lung cancer
Lung cancer is the leading cause of cancer mortality worldwide. Non-small-cell lung cancer (NSCLC) is the most common type. One-fifth of patients present with stage 3 or locally advanced (LA) disease, equating to approximately 9,000 patients annually in England. Read more
Advanced Data Fusion Learning-Driven Computer-Aided Diagnosis Model for Lung Cancer
Lung cancer is a leading cause of cancer-related deaths worldwide. Early detection of lung cancer can improve treatment outcome, but it is often challenging due to the complexity of disease. Read more
Studying lymph node stroma-immune interactions in lung cancer to improve immunotherapy
We are seeking to appoint a PhD research student to join the translational tumour immunology group led by Dr Alan G. Ramsay and Dr Anthony Kong, as part of an industrial collaboration with Dr Rachel Evans, AstraZeneca (Industrial CASE, iCASE studentship). Read more
Identification of lung cancer patients at higher risk for brain metastasis using microfluidics
Applications are invited for a three-year PhD studentship. The studentship will start on 1st January 2025. . Project Description. Read more
Driving phenotypic plasticity and metastasis in small cell lung cancer
Small cell lung cancer (SCLC) is an aggressive malignancy with poor prognosis. Underlying this aggressiveness is intra-tumoural heterogeneity driven by phenotypic plasticity wherein tumour cells transition from a neuroendocrine (NE) to a non-neuroendocrine (non-NE) phenotype. Read more
(MCRC Non-Clinical) Investigation of the role of the small GTPase RAC1 in invasion and metastasis of Small Cell Lung Cancer
Small cell lung cancer (SCLC) is an aggressive tumour, where 80% of patients have metastatic disease at diagnosis. Underlying this aggressiveness is intra-tumoural heterogeneity. Read more
(MRC DTP) Investigating the link between nuclear deformation and lung cancer migration and invasion
Migration and invasion are essential features of malignant cells that underlie metastatic potential. Controlling nuclear size, shape, orientation, and position along a cell’s front-rear axis is crucial for optimal directional migration and invasion. Read more
Repurposing and enriching cardiovascular risk prediction model to identify people at risk of cancer – UCL (part of Health Data Research UK’s Big Data for Complex Disease Driver Programme)
Risk-stratified management of cardiovascular disease (CVD), where people without established disease receive preventative interventions and monitoring based on their 10-years predicted risk, has been highly successful to ensure healthcare resources are allocated to those most likely to benefit. Read more
Inducing ferroptotic death to kill cancer cells
Ferroptosis is an iron-dependent form of regulated necrotic cell death triggered by oxidative degradation of lipids in membrane bilayers and subsequent irreparable damages to the plasma membrane (1). Read more
Can targeting extracellular vesicle release sensitise head and neck cancer cells to chemotherapy treatment?
Project details. Extracellular vesicles (EVs) are nanosized membrane enclosed particles that are produced by all cell types that have been tested. Read more
Computational and machine learning driven development of new polysialyltransferase (ST8SiaII) inhibitors against metastatic cancer
Research Group:
Institute of Cancer Therapeutics
Polysialic acid (polySia) is a carbohydrate polymer important for embryonic development. PolySia is absent in healthy adult tissues whereas overexpressed in several tumours. Read more